TorreyPines Therapeutics Report issue

For profit Phase 1 Phase 2
Founded: La Jolla CA United States (2000)
Status: Acquired by Raptor Pharmaceuticals Corp. (2009) → now Amgen

Organization Overview

First Clinical Trial
2006
NCT00567086
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2008

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Active Ingredients

Drugs in Phase 2 Trials (2)

ngx267 (1 trial)

tezampanel (1 trial)

Drugs in Phase 1 Trials (1)

ngx426 (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Hyperalgesia (Phase 1)

Migraine Disorders (Phase 2)

Sjogren's Syndrome (Phase 2)

Syndrome (Phase 2)

Xerostomia (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 3
  • # of Trial APIs: 3